Implementing best practices on data generation and reporting of Mycobacterium tuberculosis in vitro assays within the ERA4TB consortium-Reference-Cited by-同舟云学术

Implementing best practices on data generation and reporting of Mycobacterium tuberculosis in vitro assays within the ERA4TB consortium

Published:2023-04 Issue:4 Volume:26 Page:106411
ISSN:2589-0042
Container-title:iScience
language:en
Short-container-title:iScience

Author:

van Wijk Rob C.,Lucía Ainhoa,Sudhakar Pavan Kumar,Sonnenkalb Lindsay,Gaudin Cyril,Hoffmann Eik,Dremierre Bérénice,Aguilar-Ayala Diana Angélica,Molin Michael Dal,Rybniker Jan,de Giorgi Stefano,Cioetto-Mazzabò Laura,Segafreddo Greta,Manganelli Riccardo,Degiacomi Giulia,Recchia Deborah,Pasca Maria Rosalia,Simonsson Ulrika S.H.,Ramón-García Santiago

Funder

Innovative Medicines Initiative

Publisher

Elsevier BV

Subject

Multidisciplinary

Reference28 articles.

1. Geneva: World Health Organization (2022). Global Tuberculosis Report 2022.

2. Covid-19’s devastating effect on tuberculosis care — a path to recovery;Pai;N. Engl. J. Med.,2022

3. Origins of combination therapy for tuberculosis: lessons for future antimicrobial development and application;Kerantzas;mBio,2017

4. The innovative Medicines initiative −10 Years of public-private collaboration;Laverty;Front. Med.,2019

5. Comment: the FAIR Guiding Principles for scientific data management and stewardship;Wilkinson;Sci. Data,2016

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Structure of the SigE regulatory network in Mycobacterium tuberculosis;Frontiers in Microbiology;2024-05-30

2. Evaluation of critical parameters in the hollow‐fibre system for tuberculosis: A case study of moxifloxacin;British Journal of Clinical Pharmacology;2024-04-17